ASH recognizes Choosing Wisely, Guideline Implementation champions
Click Here to Manage Email Alerts
ASH recognized three Choosing Wisely champions and three guideline implementation champions at this year’s ASH Annual Meeting and Exposition.
The American Board of Internal Medicine (ABIM) Foundation’s Choosing Wisely campaign is designed to reduce unnecessary expenses without sacrificing quality care. The goal is to encourage patient-provider conversations about the necessity and potential harm of certain procedures.
Through this initiative, ASH identified 15 commonly used hematology treatments, tests and procedures that clinicians and patients should question.
Choosing Wisely champions have implemented successful efforts at their institutions to advance the goals of this effort and improve quality at their institutions.
The newest ASH Choosing Wisely champions are:
Carol M. Mathew, MD, assistant professor of hematology/oncology at University of Florida, for reducing unnecessary pre-medication prior to parenteral iron therapy;
Kamal Kant Sahu, MD, clinical fellow in hematology and medical oncology at University of Utah's Huntsman Cancer Institute, for implementation of a new electronic medical record algorithm to streamline the appropriate use of rasburicase; and
Daanish Hoda, MD, oncologist at Intermountain LDS Hospital, for decreasing the rate of Clostrididoides difficile infection overdiagnoses and treatment by instituting an algorithm for clinicians to follow prior to testing.
ASH’s new guideline implementation champions initiative recognizes practitioners working to implement evidence-based guideline recommendations in their respective clinical settings.
The inaugural ASH guideline implementation champions are:
W. Andrés Vásconez Samaniego, MD, for efforts at University of Miami/Holtz Children’s Hospital to reduce time to analgesia during care of sickle cell disease vaso-occlusive events using current guidelines from ASH and the National Heart Lung Blood Institute;
Jordan Schaefer, MD, FACP, oncologist at University of Michigan, for reducing excess aspirin use among patients on chronic anticoagulation for venous thromboembolic disease; and
Jori E. May, MD, assistant professor of medicine in the division of hematology/oncology at The University of Alabama at Birmingham, for improving the diagnosis and management of heparin-induced thrombocytopenia with automatic electronic consultation.
Read more about
Click Here to Manage Email Alerts